Inventor
ZHUSHOU LUO
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes27%
C07DHeterocyclic compounds27%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
C07CAcyclic or carbocyclic compounds7%
PatentTitleYear
12,459,941Tricyclic IRAK inhibitors202512,441,723Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations202512,357,623Method for treating a disease or condition using a pyrazole compound or formulation thereof202512,043,629RIP1K inhibitors202411,584,758RIP1K inhibitors202311,578,078Heterocyclic RIP1 inhibitory compounds202311,564,930RIP1 inhibitory compounds and methods for making and using the same202311,407,736RIP1 inhibitory compounds and methods for making and using the same202211,370,787Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to RIGEL PHARMACEUTICALS INC (9)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RIGEL PHARMACEUTICALS INC | 9 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2025 |